GB1462298A - Antibody productive hb ag vaccine and process for its preparation - Google Patents

Antibody productive hb ag vaccine and process for its preparation

Info

Publication number
GB1462298A
GB1462298A GB3604674A GB3604674A GB1462298A GB 1462298 A GB1462298 A GB 1462298A GB 3604674 A GB3604674 A GB 3604674A GB 3604674 A GB3604674 A GB 3604674A GB 1462298 A GB1462298 A GB 1462298A
Authority
GB
United Kingdom
Prior art keywords
vaccine
preparation
protein
antibody formation
productive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3604674A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREEN CROSS CORP
Original Assignee
GREEN CROSS CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GREEN CROSS CORP filed Critical GREEN CROSS CORP
Publication of GB1462298A publication Critical patent/GB1462298A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB3604674A 1974-01-28 1974-08-15 Antibody productive hb ag vaccine and process for its preparation Expired GB1462298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1161774A JPS5523254B2 (fr) 1974-01-28 1974-01-28

Publications (1)

Publication Number Publication Date
GB1462298A true GB1462298A (en) 1977-01-19

Family

ID=11782869

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3604674A Expired GB1462298A (en) 1974-01-28 1974-08-15 Antibody productive hb ag vaccine and process for its preparation

Country Status (6)

Country Link
JP (1) JPS5523254B2 (fr)
CA (1) CA1023662A (fr)
CH (1) CH617350A5 (fr)
DE (1) DE2440926C3 (fr)
FR (1) FR2258864B1 (fr)
GB (1) GB1462298A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599007B2 (en) * 1984-10-02 1990-07-12 New York Blood Center, Inc., The Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1571829A (en) 1976-04-06 1980-07-23 Lafon Labor Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds
JPS591981B2 (ja) * 1976-08-27 1984-01-14 株式会社ミドリ十字 ＨＢｓ抗体検出用受身赤血球凝集試験用担体の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599007B2 (en) * 1984-10-02 1990-07-12 New York Blood Center, Inc., The Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Also Published As

Publication number Publication date
JPS50105817A (fr) 1975-08-20
CA1023662A (fr) 1978-01-03
CH617350A5 (en) 1980-05-30
FR2258864A1 (fr) 1975-08-22
DE2440926B2 (de) 1978-04-06
JPS5523254B2 (fr) 1980-06-21
DE2440926C3 (de) 1978-11-30
FR2258864B1 (fr) 1978-06-30
DE2440926A1 (de) 1975-07-31

Similar Documents

Publication Publication Date Title
NL930015I2 (nl) Werkwijze ter bereiding van nonapepide-aminederivaten, en farmaceutische preparaten met ovulatie-opwekkende werking daaruit.
SE9102975D0 (sv) Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES487106A0 (es) Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
NL178594C (nl) Werkwijze ter bereiding van geneesmiddelen met antihypertensieve werking, alsmede werkwijze ter bereiding van 2-(gesubstitueerd amino)4-amino 6,7,8-trimethoxychinazolinen, geschikt voor gebruik bij eerstgenoemde werkwijze.
JPS5461112A (en) Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
NL181628C (nl) Werkwijze voor het bereiden van farmaceutische preparaten met prostaglandine-achtige werking, alsmede werkwijze voor het bereiden van 9alfa,11alfa,15alfa-trihydroxy-prosta-4,5,13-trieenzuurderivaten, geschikt voor gebruik bij de eerstgenoemde werkwijze.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
SE7600284L (sv) Terapeutisk insulinberedning.
ATE43968T1 (de) Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.
NL7506245A (nl) Werkwijze voor het bereiden van een preparaat voor een de plantengroei regulerende werking, gevormde preparaten verkregen onder toepassing van deze werkwijze, verbindingen met een de plantengroei regulerende werking, alsmede voor het bereiden van deze verbindingen.
DE3689622D1 (de) Impfstoffe gegen menschliche respiratorische viren.
GB1462298A (en) Antibody productive hb ag vaccine and process for its preparation
ES8102805A1 (es) Procedimiento mejorado para purificar polisacaridos capsula-res
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
GB1442564A (en) Process for preparing inactivated hb ag vaccine
NL7500224A (nl) Werkwijze voor het bereiden van prostaglandine- oga; werkwijze ter bereiding van farmaceu- e preparaten, alsmede de door toepassing an vervaardigde voorwerpen.
GB984074A (en) Antigen products and production thereof
SE7508857L (sv) Forfarande for framstellning av 19,20-bis-norprostansyror.
SE7704245L (sv) Medel for profylax och terapi av gastroenterit
NL7503743A (nl) Werkwijze voor het bereiden van pyridylalkyl- amidinen, werkwijze voor het bereiden van far- maceutische preparaten met antihyperglycaemische werking alsmede hierbij verkregen gevormde pre- paraten.
NL158783B (nl) Werkwijze voor het bereiden van farmaceutische preparaten met antifibrinolytische werking, door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van antifibrinolytisch werkzame aminozuren.
NL7603767A (nl) Werkwijze voor de bereiding van nieuwe farmaceu- tische preparaten, alsmede preparaten verkregen volgens deze werkwijze.
GB916455A (en) Non-toxic antigens and process for producing same
GB1437006A (en) Antidistemper and anti-hepatitis vaccines
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920815